Once an EUA is granted, ongoing monitoring and data collection are essential to ensure the product's safety and efficacy. Regulatory agencies may require manufacturers to continue clinical trials and submit additional data. If sufficient evidence confirms the product's benefits and risks, it may eventually receive full approval.
